Kala Bio Inc
(LTS:0JQ2)
$
5.9182
0.0432 (0.74%)
Market Cap: 16.79 Mil
Enterprise Value: 4.87 Mil
PE Ratio: 0
PB Ratio: 2.52
GF Score: 35/100 - KALA BIO Inc at HC Wainwright Ophthalmology Virtual Conference - Pre Recorded TranscriptAug 16, 2023
- Kala Pharmaceuticals Inc at Jefferies Healthcare Conference TranscriptJun 09, 2023
- Q2 2022 Kala Pharmaceuticals Inc Earnings Call TranscriptAug 11, 2022$20 (+18.34%)Earnings
- Q1 2022 Kala Pharmaceuticals Inc Earnings Call TranscriptMay 16, 2022$33.15Earnings
- Q4 2021 Kala Pharmaceuticals Inc Earnings Call TranscriptMar 29, 2022$70 (-19.17%)Earnings
- Q3 2021 Kala Pharmaceuticals Inc Earnings Call TranscriptNov 15, 2021$107.5 (+3.86%)Earnings
- Q2 2021 Kala Pharmaceuticals Inc Earnings Call TranscriptAug 05, 2021$154.25 (-9.48%)Earnings
- Kala Pharmaceuticals Inc at BofA Securities 2021 Healthcare Conference (Virtual) TranscriptMay 13, 2021
- Q1 2021 Kala Pharmaceuticals Inc Earnings Call TranscriptMay 05, 2021$299 (-8.11%)Earnings
- Q4 2020 Kala Pharmaceuticals Inc Earnings Call TranscriptFeb 25, 2021$402.25 (-8.87%)Earnings
- Kala Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 13, 2021
- Q3 2020 Kala Pharmaceuticals Inc Earnings Call TranscriptNov 05, 2020$350.5Earnings
- Kala Pharmaceuticals, Inc. - Special Call TranscriptOct 27, 2020
- Kala Pharmaceuticals, Inc. - Special Call TranscriptSep 17, 2020
- Q2 2020 Kala Pharmaceuticals Inc Earnings Call TranscriptAug 06, 2020$507.48Earnings
- Kala Pharmaceuticals Inc Annual Shareholders Meeting TranscriptJun 25, 2020
- Kala Pharmaceuticals Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) TranscriptMay 13, 2020
- Q1 2020 Kala Pharmaceuticals Inc Earnings Call TranscriptMay 07, 2020$532.5Earnings
- Kala Pharmaceuticals Inc STRIDE 3 Data Conference Call TranscriptMar 09, 2020
- Q4 2019 Kala Pharmaceuticals Inc Earnings Call TranscriptFeb 12, 2020$318.48Earnings
- Kala Pharmaceuticals Inc at JPMorgan Healthcare Conference TranscriptJan 15, 2020
- Q3 2019 Kala Pharmaceuticals Inc Earnings Call TranscriptNov 07, 2019$250.75Earnings
- Q2 2019 Kala Pharmaceuticals Inc Earnings Call TranscriptAug 06, 2019$250.75 (-18.98%)Earnings
- Kala Pharmaceuticals Inc at Bank of America Merrill Lynch Health Care Conference TranscriptMay 14, 2019
- Q1 2019 Kala Pharmaceuticals Inc Earnings Call TranscriptMay 09, 2019$408Earnings
- Q4 2018 Kala Pharmaceuticals Inc Earnings Call TranscriptMar 11, 2019Earnings
Kala Pharmaceuticals Inc at Jefferies Healthcare Conference Transcript
Jun 09, 2023 / 03:55PM GMT
Release Date Price:
$14.82
Chris Howerton
(Trades, Portfolio) LLC - Analyst
Okay. Hi, everybody. Thank you so much for joining us. My name is Chris Howerton, part of the Jefferies biotechnology research team. Very excited to see everybody here at our healthcare conference for the third day. And we are hosting a fireside chat with our next company, Kala Pharmaceuticals.
And on behalf of the company, we have Kim Brazzell, the CMO. Thanks for joining us here.
Kim Brazzell;Chris Howerton
Kala Pharmaceuticals, Inc - Head, R&D & Chief Medical Officer; (
It's great to be here. My colleague, Todd Bazemore couldn't make it because flight got canceled, because of the smoke.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)